TSHA-102

DB18599InvestigationalGene Therapies

TSHA-102 is a recombinant serotype 9 adeno-associated virus encoding a codon-optimized human MECP2 gene.

Code names
TSHA-102

Resolves to

Compound
UNIINVK87P6NXW

What you can answer from here — as of November 27, 2025

3Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of TSHA-102, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In